Alkermes News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.24	Alkermes Plc Q3 Profit Increases, But Misses Estimates (RTTNews)
24.07.24	Alkermes Reiterates FY24 Revenue Outlook - Update (RTTNews)
24.07.24	Alkermes Plc Q2 Profit Drops, Inline With Estimates (RTTNews)
01.05.24	Alkermes plc Q1 Earnings Summary (RTTNews)
15.02.24	Alkermes plc Q4 Earnings Summary (RTTNews)
03.01.24	Alkermes Reports Results From Long-Term Safety And Durability Of Treatment Effect Study Of LYBALVI (RTTNews)
14.12.23	Alkermes To Sell Development And Manufacturing Facility In Athlone - Quick Facts (RTTNews)
02.12.23	Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
15.11.23	Alkermes Completes Separation Of Oncology Business; Updates 2023 Guidance (RTTNews)
23.10.23	Alkermes : Initial ALKS 2680 Data Show Dose-Dependent, Improved Sleep Latency In Narcolepsy Type 1 (RTTNews)
31.08.23	Alkermes Announces Recipients of 2023 Alkermes Inspiration Grants® Program (PR Newswire)
30.08.23	Alkermes Grants Teva License To Market Generic VIVITROL Beginning In Jan., 2027 (RTTNews)
28.06.23	Sarissa Capital Calls For Shareholder Presence At Alkermes' Board (RTTNews)
13.06.23	Alkermes Board Recommends Shareholders Vote For All Seven Of Its Director Nominees (RTTNews)
06.06.23	Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration (RTTNews)
26.04.23	Alkermes Q1 Adj. Profit Declines; Reiterates 2023 Financial Expectations (RTTNews)
26.04.23	Alkermes plc Q1 Earnings Summary (RTTNews)
16.02.23	Alkermes plc Q4 Earnings Summary (RTTNews)
17.01.23	Alkermes: Nemvaleukin Alfa Gets UK MHRA's Innovation Passport Designation To Treat Mucosal Melanoma (RTTNews)
02.11.22	Alkermes plc Q3 Earnings Summary (RTTNews)
17.10.22	Acorda Announces $16.5 Mln Award And Royalty/Supply Relief In AMPYRA Arbitration Case With Alkermes (RTTNews)
27.07.22	Alkermes Plc Raises 2022 Guidance (RTTNews)
27.07.22	Alkermes plc Q2 Earnings Summary (RTTNews)
06.07.22	Sarissa To Vote For Alkermes Slate Of Directors (RTTNews)
27.04.22	Alkermes Reiterates FY22 Outlook; Q1 Results Top Estimates (RTTNews)
16.02.22	Alkermes plc Q4 Earnings Summary (RTTNews)
06.01.22	New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey (PR Newswire)
27.10.21	Alkermes plc Q3 adjusted earnings Beat Estimates (RTTNews)
26.10.21	Alkermes Initiates ARTISTRY-7 Phase 3 Trial of Nemvaleukin Alfa in Patients With Platinum-Resistant Ovarian Cancer (PR Newswire)
25.10.21	Alkermes Gets Fast Track Status For Nemvaleukin Alfa- Pembrolizumab Combination In Ovarian Cancer (RTTNews)
25.10.21	Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer (PR Newswire)
18.10.21	Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder (PR Newswire)
22.09.21	New Survey Provides Insights Into Drinking Behaviors During the Pandemic (PR Newswire)
02.08.21	Alkermes Gets Fast Track Designation For Nemvaleukin - Quick Facts (RTTNews)
02.08.21	Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma (PR Newswire)
02.08.21	Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma (PR Newswire)
28.07.21	Alkermes Boosts FY21 Outlook - Quick Facts (RTTNews)
28.07.21	Alkermes plc Q2 adjusted earnings Beat Estimates (RTTNews)
28.07.21	Alkermes plc Reports Second Quarter 2021 Financial Results (PR Newswire)
28.07.21	Alkermes plc Reports Second Quarter 2021 Financial Results (PR Newswire)
23.07.21	Alkermes Announces Recipients of 2021 Alkermes Inspiration Grants® Program (PR Newswire)
23.07.21	Alkermes Announces Recipients of 2021 Alkermes Inspiration Grants® Program (PR Newswire)
21.07.21	Alkermes to Report Second Quarter 2021 Financial Results on July 28, 2021 (PR Newswire)
21.07.21	Alkermes to Report Second Quarter 2021 Financial Results on July 28, 2021 (PR Newswire)
22.06.21	Alkermes Announces Former Professional Baseball Player, CC Sabathia, as Spokesperson for Alcohol Dependence Awareness Campaign (PR Newswire)
22.06.21	Alkermes Announces Former Professional Baseball Player, CC Sabathia, as Spokesperson for Alcohol Dependence Awareness Campaign (PR Newswire)
30.04.21	Alkermes Grants Sarissa Right To Designate Director To Board (RTTNews)
28.04.21	Alkermes plc Q1 adjusted earnings Beat Estimates (RTTNews)
07.04.21	Alkermes In Clinical Trial Collaboration With Merck-Quick Facts (RTTNews)
11.03.21	Alkermes Announces Orphan Drug Designation For Nemvaleukin Alfa - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Alkermes PLC

Aktien Top/Flop

Meistgelesene Nachrichten